Specialty Pharmaceutical Company dedicated to patients living with chronic conditions

Filing date Description Form Filing Group Filer View

Notification that form type 10-Q will be submitted late

NT 10-Q
Quarterly Filings
0001096906-03-000285.pdf 0001096906-03-000285.rtf View HTML

An amendment to the SC 13G filing

SC 13G/A
3,4,5
PHARMACEUTICAL PRODUCT DEVELOPMENT INC 0001021408-03-006893.pdf 0001021408-03-006893.rtf View HTML

Initial filing by director officer or owner of more than ten percent.

3
3,4,5
PHARMACEUTICAL PRODUCT DEVELOPMENT INC 0001003124-03-000001.pdf 0001003124-03-000001.rtf 0001003124-03-000001.xls View HTML

Report of unscheduled material events or corporate event

8-K
Current Reports
0001096906-03-000208.pdf 0001096906-03-000208.rtf View HTML

Report of unscheduled material events or corporate event

8-K
Current Reports
0001096906-03-000168.pdf 0001096906-03-000168.rtf View HTML

Annual report filed by small businesses

10KSB
Annual Filings
0001096906-03-000153.pdf 0001096906-03-000153.rtf 0001096906-03-000153.xls View HTML

Report of unscheduled material events or corporate event

8-K
Current Reports
0001096906-03-000087.pdf 0001096906-03-000087.rtf 0001096906-03-000087.xls View HTML

Report of unscheduled material events or corporate event

8-K
Current Reports
0001096906-03-000013.pdf 0001096906-03-000013.rtf View HTML

Quarterly report filed by small businesses

10QSB
Quarterly Filings
0001096906-02-000877.pdf 0001096906-02-000877.rtf 0001096906-02-000877.xls View HTML

Statement of changes in beneficial ownership of securities

4
3,4,5
STONE WILLIAM B 0001096906-02-000785.pdf 0001096906-02-000785.rtf 0001096906-02-000785.xls View HTML

Copyright Morningstar

BioDelivery Sciences Acquires U.S. Commercial Rights to Symproic®
Thank you. We will get back to you soon